Transcriptional silencing of fetal hemoglobin by BCL11A

Annals of the New York Academy of Sciences

Volumn 1202, Issue , 2010, Pages 64-68

  Sankaran, Vijay G ^a,b   Xu, Jian ^a,b,c   Orkin, Stuart H ^a,b,c  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

BCL11A; fetal hemoglobin; globin switching; thalassemia; transcription

Indexed keywords

HEMOGLOBIN F;

BCL11A GENE; BETA THALASSEMIA; CONFERENCE PAPER; ERYTHROID CELL; GENE; GENE EXPRESSION; GENE LOCUS; GENE SILENCING; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; GLOBIN GENE; HUMAN; REGULATORY SEQUENCE;

EID: 77955866470     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2010.05574.x     Document Type: Conference Paper

References (28)

1. Weatherall, D., O. Akinyanju, S. Fucharoen, et al. 2006. Inherited disorders of hemoglobin.DiseaseControl Priorities in Developing Countries, 2nd ed.: 663-680. Oxford University Press. New York.
2. Weatherall, D.J. 2001. Phenotype-genotype relationships in monogenic disease: lessons fromthe thalassaemias. Nat. Rev. Genet. 2: 245-255.
3. Premawardhena, A., C.A. Fisher, N.F. Olivieri, et al. 2005. Haemoglobin E beta thalassaemia in Sri Lanka. Lancet 366: 1467-1470.
4. Rund,D.&E.Rachmilewitz. 2005. Beta-thalassemia. N.Engl. J. Med. 353: 1135-1146.
5. Olivieri, N.F. 1999. The beta-thalassemias. N. Engl. J. Med. 341: 99-109.
6. Stamatoyannopoulos, G. 2005. Control of globin gene expression during development and erythroid differentiation. Exp. Hematol. 33: 259-271.
7. Bank, A. 2006. Regulation of human fetal hemoglobin: new players, new complexities. Blood 107: 435-443.
8. Thein, S.L. & S. Menzel. 2009. Discovering the genetics underlying foetal haemoglobin production in adults. Br. J. Haematol. 145: 455-467.
9. Thein, S.L., S.Menzel,X.Peng, et al. 2007. Intergenic variants of HBS1L-MYBare responsible for amajor quantitative trait locus on chromosome 6q23 influencing fetal hemoglobin levels in adults. Proc. Natl Acad. Sci. USA 104: 11346-11351.
10. Craig, J.E., J. Rochette, C.A. Fisher, et al. 1996. Dissecting the loci controlling fetal haemoglobin production on chromosomes 11p and 6q by the regressive approach.Nat. Genet. 12: 58-64.
11. Menzel, S., C. Garner, I. Gut, et al. 2007. A QTL influencing F cell production maps to a gene encoding a zincfinger protein on chromosome 2p15. Nat. Genet . 39: 1197-1199.
12. Uda, M., R. Galanello, S. Sanna, et al. 2008. Genome-wide association study shows BCL11A associated with persistent fetal hemoglobin and amelioration of the phenotype of betathalassemia. Proc. Natl Acad. Sci. USA 105: 1620-1625.
13. Lettre, G., V.G. Sankaran, M.A. Bezerra, et al. 2008. DNA polymorphisms at the BCL11A, HBS1L-MYB, and betaglobin loci associate with fetal hemoglobin levels and pain crises in sickle cell disease. Proc. Natl Acad. Sci. USA 105: 11869-11874.
14. Creary, L.E., P. Ulug, S. Menzel, et al. 2009. Genetic variation on chromosome 6 influences F cell levels in healthy individuals of African descent and HbF levels in sickle cell patients. PLoS One 4: e4218.
15. Solovieff, N., J.N. Milton, S.W. Hartley, et al. 2010. Fetal hemoglobin in sickle cell anemia: genome-wide association studies suggest a regulatory region in the 5′ olfactory receptor gene cluster. Blood 115: 1815-1822.
16. Sedgewick, A.E., N. Timofeev, P. Sebastiani, et al. 2008. BCL11A is a major HbF quantitative trait locus in three different populations with beta-hemoglobinopathies. Blood Cells Mol. Dis. 41: 255-258.
17. Platt, O.S., D.J. Brambilla, W.F. Rosse, et al. 1994. Mortality in sickle cell disease. Life expectancy and risk factors for early death.N. Engl. J. Med. 330: 1639-1644.
18. Platt, O.S., B.D. Thorington, D.J. Brambilla, et al. 1991. Pain in sickle cell disease. Rates and risk factors. N. Engl. J. Med. 325: 11-16.
19. Castro, O., D.J. Brambilla, B. Thorington, et al. 1994. The acute chest syndrome in sickle cell disease: incidence and risk factors. The Cooperative Study of Sickle Cell Disease. Blood 84: 643-649. (Pubitemid 24215969)
20. Galanello, R., S. Sanna, L. Perseu, et al. 2009. Amelioration of Sardinian beta0 thalassemia by genetic modifiers. Blood 114: 3935-3937.
21. Nuinoon, M., W. Makarasara, T. Mushiroda, et al. 2010. A genome-wide association identified the common genetic variants influence disease severity in beta(0)- thalassemia/hemoglobin E. Hum. Genet. 127: 303-314.
22. Sankaran, V.G., T.F. Menne, J. Xu, et al. 2008. Human fetal hemoglobin expression is regulated by the developmental stage-specific repressor BCL11A. Science 322: 1839-1842.
23. Liu,P., J.R. Keller,M.Ortiz, et al. 2003. Bcl11a is essential for normal lymphoid development. Nat. Immunol. 4: 525-532.
24. Fathallah, H., R.S.Weinberg, Y. Galperin, et al. 2007. Role of epigenetic modifications in normal globin gene regulation and butyrate-mediated induction of fetal hemoglobin. Blood 110: 3391-3397.
25. Cao, H., G. Stamatoyannopoulos & M. Jung. 2004. Induction of human gamma globin gene expression by histone deacetylase inhibitors. Blood 103: 701-709.
26. Ragoczy, T., M.A. Bender, A. Telling, et al. 2006. The locus control region is required for association of the murine beta-globin locus with engaged transcription factories during erythroid maturation. Genes Dev. 20: 1447-1457.
27. Phillips, J.D., D.P. Steensma, M.A. Pulsipher, et al. 2007. Congenital erythropoietic porphyria due to a mutation in GATA1: the first trans-acting mutation causative for a human porphyria. Blood 109: 2618-2621.
28. Sankaran, V.G., J. Xu, T. Ragoczy, et al. 2009. Developmental and species-divergent globin switching are driven by BCL11A. Nature 460: 1093-1097.